Important insulin-sensitizing, anti-steatotic, and anti-inflammatory actions have been attributed to adiponectin, but its production is paradoxically diminished in obesity and NAFLD [53,54] (Figure 1). The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.